Aptar Pharma Company Profile

23:02 EDT 22nd July 2019 | BioPortfolio

This approval again demonstrates Aptar Pharma’s expertise in developing patient-friendly drug delivery solutions for breakthrough medicines. Aptar Pharma offers a broad portfolio of innovative technologies and wide array of services to meet the highest quality standards of the pharmaceutical industry.

News Articles [994 Associated News Articles listed on BioPortfolio]

Aptar Pharma to showcase connected devices at Pharmapack

Leading drug delivery systems provider Aptar Pharma will be exhibiting its products at Pharmapack 2019, the company has announced.

Aptar Pharma secures approval in US for Bidose nasal drug delivery device

Aptar Pharma said the approval marks the first FDA nod and US launch of a prescription drug using its patented Bidose nasal spray delivery system. The company noted The post Aptar Pharma secures appr...

Aptar Pharma showcases connected devices at Pharmapack

Leading drug delivery systems provider Aptar Pharma has showcased its latest connected devices at Pharmapack.

Aptar acquires Nanopharm and Gateway Analytical to speed up drug development

Aptar Pharma has acquired two leading analytical services as part of a strategy to broaden its portfolio and help accelerate and derisk complex product developments.

Santen preservative free drug approved for Aptar Pharma device

Drug delivery systems provider Aptar Pharma has announced its preservative-free multidose Ophthalmic Squeeze Dispenser has been approved for a drug developed for to help glaucoma patients.

Aptar scoops up two pharma services firms in $50m deal

Aptar Group acquires two pharmaceutical services companies, Nanopharm and Gateway Analytical, to boost its analytical, testing, and development capabilities.

Aptar Pharma to exhibit latest innovations in drug delivery devices at Pharmapack 2019

Aptar Pharma, a leading drug delivery systems provider, will once again be a major exhibitor at Pharmapack 2019, which will take place February 6-8 at Paris Expo, Porte de Versailles, in Paris, France

Aptar acquires Nanopharm and Gateway Analytical to accelerate customer drug development

The acquisitions are part of Aptar’s strategy to broaden its portfolio of services that support pharmaceutical and biotech customers to accelerate and derisk their complex product developments. Both...

Drugs and Medications [53 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [mayne pharma inc]

Fluoride Chewable Tablets 0.5 mg

Fluoride [mayne pharma inc]

Fluoride Chewable Tablets 1 mg

Urea [mayne pharma inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [aventis pharma ltd.]


Ribavirin [aurobindo pharma limited]


PubMed Articles [24 Associated PubMed Articles listed on BioPortfolio]

Data science tools and applications on the way to Pharma 4.0.

Multiple obstacles are driving the digital transformation of the biopharmaceutical industry. Novel digital techniques, often marketed as 'Pharma 4.0', are thought to solve some long-existing obstacles...

The Art of Virtualizing Pharma R&D.

Physicians in the pharmaceutical industry: their roles, motivations, and perspectives.

Although physicians occupy a significant number of key positions in the pharmaceutical industry, practicing clinicians are often unaware of the variety of career paths within this industry, or of the ...

Establishing and Maintaining a Robust Sample Management System.

This paper has been written by the SLAS Sample Management Special Interest Group to serve as a guide to the best practices and methods in establishing and maintaining a high-quality sample management ...

Potential effects of increased openness in pharma: the original knowledge behind new drugs.

This study seeks to determine potential changes in the degree of openness in pharmaceutical R&D by investigating where the knowledge behind new molecular entities (NMEs) comes from in terms of type of...

Clinical Trials [91 Associated Clinical Trials listed on BioPortfolio]

Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301

The primary objective of this study is to determine whether etripamil nasal spray (NS) 70 mg is superior to placebo at terminating episodes of PSVT in an outpatient setting.

Acute Treatment Trial in Adult Subjects With Migraines

This study will evaluate the safety and efficacy of three different intranasal dose levels of BHV-3500, relative to placebo, in the acute treatment of moderate to severe migraine.

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

Companies [819 Associated Companies listed on BioPortfolio]

Aptar Pharma

This approval again demonstrates Aptar Pharma’s expertise in developing patient-friendly drug delivery solutions for breakthrough medicines. Aptar Pharma offers a broad portf...

AptarGroup, Inc.

AptarGroup, Inc. (NYSE: ATR) is a leading global supplier of a broad range of innovative drug delivery devices and dispensing and sealing solutions for the pharmaceutical, beauty,...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

More Information about "Aptar Pharma" on BioPortfolio

We have published hundreds of Aptar Pharma news stories on BioPortfolio along with dozens of Aptar Pharma Clinical Trials and PubMed Articles about Aptar Pharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aptar Pharma Companies in our database. You can also find out about relevant Aptar Pharma Drugs and Medications on this site too.

Quick Search

Relevant Topics

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...

A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Corporate Database Quicklinks

Searches Linking to this Company Record